Osenvelt Injection
Product Images NDC 72606-038

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Osenvelt (NDC 72606-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Osenvelt 01)

This description provides data on corrected calcium levels in mmol/L and mg/dL, with values ranging from 20 to 4.0 mmol/L and showing corresponding values in mg/dL. It also includes information related to Denosumab administration, with specific dosage data for 23 individuals and their corresponding study days. Additionally, the text mentions study day time points and provides information on changes in calcium levels during Denosumab treatment.*

FDA Label Image

Principal Display Panel (120 mg/1.7 mL Vial Carton)

The text contains information about a medication called "Osenvelt" (denosumab-bmwo) in an injectable form with a dosage of 120 mg/1.7 mL for subcutaneous use. It should be stored refrigerated at 2°C to 8°C and should not be frozen or shaken. The medication is manufactured by CELLTRION, Inc. and distributed by CELLTRION USA, Inc. It is a single-dose vial and any unused portion should be discarded. Administration is recommended by a healthcare provider. The product is a single vial and is a product of the Republic of Korea.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.